Effects of preoperative immunochemoradiotherapy and chemoradiotherapy on immune responses in patients with rectal adenocarcinoma

Anticancer Res. 2010 Mar;30(3):993-9.

Abstract

Background: We previously reported that preoperative chemoradiotherapy (CRT) combined with intraoperative electron irradiation for cT3/T4 adenocarcinoma of the rectum reduced the local recurrence, with significant improvement of survival. Radiotherapy has been reported to reduce immune function. We examined the effects of PSK, a protein-bound polysaccharide, concomitant with preoperative CRT on immune responses.

Patients and methods: Thirty patients with cT3/T4 adenocarcinoma of the rectum were randomly assigned to 2 weeks' irradiation and 4 weeks' S-1 administration before surgery (control group), or the same CRT with simultaneous 4 weeks' PSK administration (PSK group). Both systemic and local immune responses were evaluated.

Results: Significant increase of natural killer cell count in the peripheral blood and cytotoxic T-cell counts in the peri-tumoral and normal mucosa, and a significant decrease of serum immunosuppressive acidic protein level were observed in the PSK group.

Conclusion: Combined use of PSK with preoperative CRT may improve immune function.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adenocarcinoma / blood
  • Adenocarcinoma / immunology*
  • Adenocarcinoma / therapy*
  • Aged
  • Combined Modality Therapy
  • Female
  • Humans
  • Immunologic Factors / therapeutic use*
  • Killer Cells, Natural / immunology
  • Male
  • Middle Aged
  • Preoperative Care / methods
  • Proteoglycans / therapeutic use*
  • Rectal Neoplasms / blood
  • Rectal Neoplasms / immunology*
  • Rectal Neoplasms / therapy*
  • T-Lymphocytes, Cytotoxic / immunology

Substances

  • Immunologic Factors
  • Proteoglycans
  • polysaccharide-K